Regular Painkiller drugs enhance risk of Breast Cancer
MIL/Agencies, Jun 1, 2005. Special Correspondent
Washington, (Prensa Latina) - The latest study by the National Cancer Institute suggests that the long-term use of painkillers like aspirin and ibuprofen is likely to increase the risk of breast cancer.
This report has appeared in a journal of the Institute, published on Wednesday. According to the study, the daily use of aspirin has more chances to increase the risk of estrogen receptor/progesterone receptor (ER/PR), negative breast tumors, while the prolonged daily use of ibuprofen may enhance the risk of non-localized breast cancer.
As per the Prensa Latin American News Agency, the study conducted by Sarah F Marshall and her team from the University of Southern California, tracked the health of 114,460 women aged between 22 and 85 years, who participated in the California Teachers Study. They compared the results.
All participants were healthy when they joined the study in 1995 and 1996, but over the next six years, 2,391 women were found to have breast cancer. The main cause is regular consumption of aspirin and ibuprofen.
The study team had an impression that they were expecting ibuprofen to reduce risk, and the same for aspirin. But these drugs are not preventing breast cancer as earlier studies suggested that they might," Sarah Marshall said.
The majority of doctors does not agree with this finding. They say that there is nothing to be panicky. This is only a study by Sarah F Marshall and her team from the University of Southern California. The opinion is divided since it is based on survey only.
|